Global NAD+ Health Products Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 NAD+ Health Products Market Overview

1.1 NAD+ Health Products Definition

1.2 Global NAD+ Health Products Market Size Status and Outlook (2019-2032)

1.3 Global NAD+ Health Products Market Size Comparison by Region (2019-2032)

1.4 Global NAD+ Health Products Market Size Comparison by Type (2019-2032)

1.5 Global NAD+ Health Products Market Size Comparison by Application (2019-2032)

1.6 Global NAD+ Health Products Market Size Comparison by Sales Channel (2019-2032)

1.7 NAD+ Health Products Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global NAD+ Health Products Market Snapshot

2.2 Global NAD+ Health Products Market Volume & Revenue (2019-2025)

2.3 Global NAD+ Health Products Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global NAD+ Health Products Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global NAD+ Health Products Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global NAD+ Health Products Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 NAD+ Health Products Market Segment Analysis by Player

3.1 Global NAD+ Health Products Sales and Market Share by Player (2023-2025)

3.2 Global NAD+ Health Products Revenue and Market Share by Player (2023-2025)

3.3 Global NAD+ Health Products Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 NAD+ Health Products Market Segment Analysis by Type

4.1 Global NAD+ Health Products Market by Type

4.1.1 NMNContent ＜98%

4.1.2 NMNContent ≥98%

4.2 Global NAD+ Health Products Sales and Market Share by Type (2019-2025)

4.3 Global NAD+ Health Products Revenue and Market Share by Type (2019-2025)

4.4 Global NAD+ Health Products Average Price by Type (2019-2025)

4.5 Leading Players of NAD+ Health Products by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 NAD+ Health Products Market Segment Analysis by Application

5.1 Global NAD+ Health Products Market by Application

5.1.1 Health Care Products

5.1.2 Beauty Products

5.1.3 Others

5.2 Global NAD+ Health Products Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of NAD+ Health Products by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 NAD+ Health Products Market Segment Analysis by Sales Channel

6.1 Global NAD+ Health Products Market by Sales Channel

6.1.1 Global NAD+ Health Products Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global NAD+ Health Products Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global NAD+ Health Products Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of NAD+ Health Products by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 NAD+ Health Products Market Segment Analysis by Region

7.1 Global NAD+ Health Products Market Size and CAGR by Region (2019-2032)

7.2 Global NAD+ Health Products Sales and Market Share by Region (2019-2025)

7.3 Global NAD+ Health Products Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America NAD+ Health Products Market Share by Type

7.4.3 North America NAD+ Health Products Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe NAD+ Health Products Market Share by Type

7.5.3 Europe NAD+ Health Products Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific NAD+ Health Products Market Share by Type

7.6.3 Asia-Pacific NAD+ Health Products Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America NAD+ Health Products Market Share by Type

7.7.3 South America NAD+ Health Products Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa NAD+ Health Products Market Share by Type

7.8.3 Middle East & Africa NAD+ Health Products Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading NAD+ Health Products Players

8.1 GeneHarbor

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Chromadex

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Herbalmax

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 EffePharm

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Kingdomway

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 NOMON Co. Ltd. (Teijin)

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 CELFULL

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Bontac

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Genex Formulas

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 EZZ

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 Maac10 Formulas

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

8.13 Elysium Health

8.13.1 Company Snapshot

8.13.2 Product/Service Offered

8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.13.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of NAD+ Health Products

9.1 Industrial Chain of NAD+ Health Products

9.2 Upstream of NAD+ Health Products

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of NAD+ Health Products

9.3.1 Leading Distributors/Dealers of NAD+ Health Products

9.3.2 Leading Consumers of NAD+ Health Products

Chapter 10. Global NAD+ Health Products Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global NAD+ Health Products Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. NAD+ Health Products Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of NAD+ Health Products (2026-2032)

11.1 Global NAD+ Health Products Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global NAD+ Health Products Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global NAD+ Health Products Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global NAD+ Health Products Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global NAD+ Health Products Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America NAD+ Health Products Import-Export (2019-2025)

12.2 Europe NAD+ Health Products Import-Export (2019-2025)

12.3 Asia Pacific NAD+ Health Products Import-Export (2019-2025)

12.4 South America NAD+ Health Products Import-Export (2019-2025)

12.5 Middle East & Africa NAD+ Health Products Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America NAD+ Health Products Demand-Supply (2019-2025)

13.2 Europe NAD+ Health Products Demand-Supply (2019-2025)

13.3 Asia Pacific NAD+ Health Products Demand-Supply (2019-2025)

13.4 South America NAD+ Health Products Demand-Supply (2019-2025)

13.5 Middle East & Africa NAD+ Health Products Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources